Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-848d4c4894-pftt2 Total loading time: 0 Render date: 2024-04-30T10:13:59.795Z Has data issue: false hasContentIssue false

Chapter 9 - Development of materials for regenerative medicine: from clinical need to clinical application

Published online by Cambridge University Press:  05 April 2013

By
Charlène Danoux ,
Rahul Tare ,
James Smith ,
Mark Bradley ,
John A. Hunt ,
Richard O. C. Oreffo  and
Pamela Habibovic
Edited by
Jan de Boer  and
Clemens A. van Blitterswijk
Jan de Boer
Affiliation:
University of Twente, Enschede, The Netherlands
Clemens A. van Blitterswijk
Affiliation:
University of Twente, Enschede, The Netherlands
Get access

Summary

Scope

Given the demographic challenges of an ageing population combined with rising patient expectation and the growing emphasis placed on cost containment by healthcare providers, economic regenerative medicine approaches for regeneration of damaged and diseased organs and tissues are a major clinical and socio-economic need. The scope of this chapter is to use skeletal regeneration as the exemplar to discuss classical and high-throughput screening approaches to biomaterials development for regenerative medicine, including choice and design of materials based on clinical need, biological assessment and regulatory issues.

Basic principles: development of materials for regenerative medicine

The increase in an ageing population in developed countries is accompanied by a growing need for replacement and repair of damaged organs and tissues. Transplantation of the patient’s own tissue is still considered the gold standard in many applications, but limited availability, and complications associated with harvesting of the so-called autograft, are becoming an important drawback. Tissues and organs from human or animal donors present issues of disease transmission and functional failure. Alternative strategies, based on biological growth factors, cell therapy and tissue-engineered constructs, are being explored as alternatives to the patient’s own tissue, but their use is hampered by biological instability and high costs. These issues demonstrate the need for strategies based on biomaterials, which are often synthetic, and thus less prone to instability problems. In addition, the fact that (synthetic) biomaterials can often be produced in large quantities and thus be available off-the-shelf is an important advantage when coping with an increasing need for regenerative approaches.

Type
Chapter
Information
Materiomics
High-Throughput Screening of Biomaterial Properties
 , pp. 155 - 176
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ratner, BD, Bryant, SJ. Biomaterials: where we have been and where we are going. Annu Rev Biomed Eng. 2004;6:41–75.CrossRefGoogle Scholar
Huebsch, N, Mooney, DJ. Inspiration and application in the evolution of biomaterial. Nature. 2009;462(7272):426–32.CrossRefGoogle Scholar
Hook, AL, Anderson, DG, Langer, R et al. High-throughput methods applied in biomaterials development and discovery. Biomaterials. 2010;31(2):187–98.CrossRefGoogle Scholar
Khan, F, Tare, RS, Kanczler, JM, Oreffo, ROC, Bradley, M. Strategies for cell manipulation and skeletal tissue engineering using high-throughput polymer blend formulation and microarray techniques. Biomaterials. 2010 Mar;31(8):2216–28.Google Scholar
Williams, DF. The Williams Dictionary of Biomaterials. Liverpool University; 1999.
Ratner, BD. A history of biomaterials. In: Ratner, B, Hoffman, AS, Schoen, FJ, Lemons, JE, eds. Biomaterials Science: An Introduction to Materials in Medicine. Elsevier; 2004. p. 10–19.
Apple, DJ. Sir Harold Ridley and his fight for sight: he changed the world so that we may better see it. SLACK Incorporated; 2006.
Davison, JA, Kleinmann, G, Apple, DJ. Intraocular lenses. In: Tasman, W, Jaeger, EA, eds. Duane’s Clinical Ophthalmology. Lippincott Williams & Wilkins; 2006.
Vongpatanasin, W, Hillis, LD, Lange, RA. Prosthetic heart valves. New Engl J Med. 1996;335(6):407–16.CrossRefGoogle Scholar
Hoerstrup, SP, Sodian, R, Daebritz, S et al. Functional living trileaflet heart valves grown in vitro. Circulation. 2000;102(90003):III–44–49.
Damien, CJ, Parsons, JR. Bone graft and bone graft substitutes: a review of current technology and applications. J Appl Biomater. 1991 Jan;2(3):187–208.Google Scholar
Dalton, P, Harvey, A, Oudega, M, Plant, G. Tissue engineering of the nervous system. In: van Blitterswijk, CA, ed. Tissue Engineering. Academic Press; 2008. p. 611–47.
Padera, RF, Schoen, FJ. Cardiovascular medical devices. In: Ratner, B, Hoffman, AS, Schoen, FJ, Lemons, JE, eds. Biomaterials Science: An Introduction to Materials in Medicine. Elsevier Academic Press; 2004. p. 470–94.
Fawcett, DW. Bone. In: Bloom, W, Fawcett, DW, eds. A Textbook of Histology. W.B. Saunders Company; 1986. p. 199–238.
Marks, SC, Hermey, DC. The structure and development of bone. In: Bilezikian, JP, Raisz, LG, Rodan, GA, eds. Principles of Bone Biology. Academic Press; 1996. p. 3–14.
Derkx, P, Nigg, AL, Bosman, FT et al. Immunolocalization and quantification of noncollagenous bone matrix proteins in methylmethacrylate-embedded adult human bone in combination with histomorphometry. Bone. 1998;22(4):367–73.CrossRefGoogle Scholar
van Gaalen, S, Kruyt, M, Meijer, G et al. Tissue engineering of bone. In: van Blitterswijk, CA, ed. Tissue Engineering. Academic Press; 2008. p. 560–610.
Davies, JE, Hosseini, MM. Histodynamic of endosseous wound healing. In: Davies, JE, ed. Bone Engineering. Em squared Inc.; 2000. p. 1–14.
Friedenstein, AY. Induction of bone tissue by transitional epithelium. Clin Orthopaed Related Res. 1968;59:21–37.CrossRefGoogle Scholar
Barradas, AM, Yuan, H, van Blitterswijk, CA, Habibovic, P. Osteoinductive biomaterials: current knowledge of properties, experimental models and biological mechanisms. Eur Cells Mater. 2011;21:407–29.CrossRefGoogle Scholar
Karageorgiou, V, Kaplan, D. Porosity of 3D biomaterial scaffolds and osteogenesis. Biomaterials. 2005;26(27):5474–91.CrossRefGoogle Scholar
Habibovic, P, Yuan, H, van Der Valk, CM et al. 3D microenvironment as essential element for osteoinduction by biomaterials. Biomaterials. 2005;26(17):3565–75.CrossRefGoogle Scholar
Habibovic, P, de Groot, K. Osteoinductive biomaterials – properties and relevance in bone repair. J Tissue Eng Regen Med. 2007;1(1):25–32.CrossRefGoogle Scholar
Covani, U, Giacomelli, L, Krajewski, A et al. Biomaterials for orthopedics: a roughness analysis by atomic force microscopy. J Biomed Mater Res A. 2007 Sep;82(3):723–30.Google Scholar
Schmitz, JP, Hollinger, JO, Milam, SB. Reconstruction of bone using calcium phosphate bone cements: A critical review. J Oral Maxillofac Surg. 1999;57(9):1122–6.CrossRefGoogle Scholar
Weiss, P, Gauthier, O, Bouler, J-M, Grimandi, G, Daculsi, G. Injectable bone substitute using a hydrophilic polymer. Bone. 1999;25(2):67S–70S.Google Scholar
Hou, Q, De Bank, PA, Shakesheff, KM. Injectable scaffolds for tissue regeneration. J Mater Chem. 2004;14(13):1915–23.CrossRefGoogle Scholar
Habibovic, P, Woodfield, T, de Groot, K, van Blitterswijk, CA. Predictive value of in vitro and in vivo assays in bone and cartilage repair – what do they really tell us about the clinical performance?Adv Exp Med Biol. 2007;585:327–60.Google Scholar
Brittberg, M, Lindahl, A. Tissue engineering of cartilage. In: van Blitterswijk, CA, ed. Tissue Engineering. Academic Press; 2008. p. 534–57.
Karam, JP, Muscari, C, Montero-Menei, CN. Combining adult stem cells and polymeric devices for tissue engineering in infarcted myocardium. Biomaterials. 2012:33(23):5683–95.Google Scholar
Jansen, JA. Animal models for studying soft tissue biocompatibiliy of biomaterials. In: An, YH, Friedman, RJ, eds. Animal Models In Orthopaedic Research. CRC Press; 1999. p. 393–405.
An, YH, Friedman, RJ. Animal models of bone defect repair. In: An, YH, Friedman, RJ, eds. Animal Models In Orthopaedic Research. CRC Press; 1999. p. 241–60.
An, YH, Friedman, RJ eds. Animal Models In Orthopaedic Research. CRC Press; 1999.
Bianco, RW, Grehan, JF, Grubbs, BC et al. Large animal models in cardiac and vascular biomaterials research and testing. In: Ratner, B, Hoffman, AS, Schoen, FJ, Lemons, JE, eds. Biomaterials Science: An Introduction to Materials in Medicine. Elsevier Academic Press; 2004. p. 379–96.
de Vries, RBM, Buma, P, Leenaars, M, Ritskes-Hoitinga, M, Gordijn, B. Reducing the number of laboratory animals used in tissue engineering research by restricting the variety of animal models. Articular cartilage tissue engineering as a case study. Tissue Eng Part B Rev. 2012;18(6):427–35.Google Scholar
Tare, RS, Khan, F, Tourniaire, G et al. A microarray approach to the identification of polyurethanes for the isolation of human skeletal progenitor cells and augmentation of skeletal cell growth. Biomaterials. 2009;30(6):1045–55.CrossRefGoogle Scholar
Khan, F, Tare, RS, Kanczler, JM, Oreffo, ROC, Bradley, M. Strategies for cell manipulation and skeletal tissue engineering using high-throughput polymer blend formulation and microarray techniques. Biomaterials. 2010;31(8):2216–28.CrossRefGoogle Scholar
Hench, LL. The story of Bioglass. J Mater Sci. Materials in medicine. 2006;17(11):967–78.Google Scholar
Reichert, JC, Saifzadeh, S, Wullschleger, ME et al. The challenge of establishing preclinical models for segmental bone defect research. Biomaterials. 2009;30(12):2149–63.CrossRefGoogle Scholar
Muschler, GF, Raut, VP, Patterson, TE, Wenke, JC, Hollinger, JO. The design and use of animal models for translational research in bone tissue engineering and regenerative medicine. Tissue Eng B Rev. 2010 9;16(1):123–45.Google Scholar
Newman, E, Turner, AS, Wark, JD. The potential of sheep for the study of osteopenia: Current status and comparison with other animal models. Bone. 1995;16(4):S277–S284.Google Scholar
Reichert, JC, Epari, DR, Wullschleger, ME et al. Establishment of a preclinical ovine model for tibial segmental bone defect repair by applying bone tissue engineering strategies. Tissue Eng B, Rev. 2010;16(1):93–104.CrossRefGoogle Scholar
Smith, JO, Aarvold, A, Tayton, ER, Dunlop, DG, Oreffo, ROC. Skeletal tissue regeneration: current approaches, challenges, and novel reconstructive strategies for an aging population. Tissue Eng. B Rev. 2011;17(5):307–20.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×